Form 4 for CI Cigna
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001225208-24-003416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-02-28 | CI | Evanko Brian C | See Remarks | A - Grant | $0.00 | +5,127 | 37.0K | +16% | $0 |
| D | 2024-03-01 | 2024-02-28 | CI | Evanko Brian C | See Remarks | A - Grant | $0.00 | +18.7K | 18.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2024-02-28 | A | A | 5,127 | $0.00 | 37,029 | D | — | — | (F1) These restricted shares vest in three equal annual installments beginning March 1, 2025. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-28 | A | A | 18,677 | $0.00 | 18,677 | D | $336.48 · 2025-03-01 to 2034-02-28 | 18,677 Common Stock, $.01 Par Value | (F3) This option vests in three equal annual installments beginning March 1, 2025. |